A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Recovery Coach Drop-in Forum
A drop-in session for recovery coaches to discuss coaching and other topics related to substance use, recovery, and coaching. This group is only open to recovery coaches and peer support specialists - please respect these requirements as this is a dedicated and protected space for those in the field needing support.
 |
Monday, 7/17/2023 6:00 pm – 7:15 pm ET |
 |
Virtual event |
 |
Intended AudienceRecovery coaches and peer support specialists who provide direct support to recoverees/patients in the field of addiction. We respectfully ask that those in supervisory roles not attend these sessions – thank you for your understanding. |
Topic: Harm Reduction
This training will focus on harm reduction techniques for nicotine and tobacco use. Participants will be able to identify evidence-based strategies that may reduce nicotine/tobacco consumption. It will cover harm reduction properties of switching from combustible cigarette consumption to electronic-nicotined delivery systems; how to individualize treatment by learning how to modify FDA-approved medications;Â and how to identify barriers to smoking cessation among individuals with substance use disorder, from both clinician and patient standpoints.
|
Tuesday, 7/18/2023 12:00 pm – 1:30 pm ET |
 |
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community. |
Topic: Buprenorphine
This training will cover a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention will be directed towards effective measures that support the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
|
Wednesday, 7/19/2023 12:00 pm – 1:00 pm ET |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine. |
Topic: ECHO
As part of the twice-monthly SUD Care Continuum ECHO series, Elisha M Wachman, MD will present the didactic entitled, "Eat, Sleep & Console Updates on Model." The didactic will be followed by a related de-identified patient case presentation from an ECHO participant along with recommendations from the panel of experts and attendees
|
Wednesday, 7/19/2023 12:00 pm – 1:15 pm ET |
|
Virtual event |
|
Intended AudienceAdvanced Practice Registered Nurses (APRN), Physicians (MD/DO), Physician Assistants (PA), Nurses (LPN/RN), Social Workers (LCSW/LICSW), Licensed Mental Health Counselors (LMHC), Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), Recovery Coaches. |
Topic: Stimulants
This one-hour course is intended to provide foundational knowledge of stimulant use disorders as well as an overview of evidence-based interventions.
|
Thursday, 7/20/2023 9:00 am – 10:00 am ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community. |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
|
Thursday, 7/20/2023 11:00 am – 12:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Addiction 101
This one-hour course is intended to provide foundational knowledge regarding addiction as a chronic medical condition as well as an overview of evidence-based interventions, including medications for addiction treatment (MAT).
|
Monday, 7/24/2023 12:00 pm – 1:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community. |
Topic: Recovery Coach Drop-in Forum
A drop-in session for recovery coaches to discuss coaching and other topics related to substance use, recovery, and coaching. This group is only open to recovery coaches and peer support specialists - please respect these requirements as this is a dedicated and protected space for those in the field needing support.
|
Monday, 7/24/2023 6:00 pm – 7:15 pm ET |
|
Virtual event |
|
Intended AudienceRecovery coaches and peer support specialists who provide direct support to recoverees/patients in the field of addiction. We respectfully ask that those in supervisory roles not attend these sessions – thank you for your understanding. |
Topic: Harm Reduction
This training will review strategies to reduce communicable infectious diseases associated with injection drug use; testing strategies and linkage to care for those patients with diagnosed blood-borne pathogens; bleaching/sterilization of injection paraphernalia, serosorting or sequential drug use to prevent infection of uninfected partners; and pharmacological interventions for infection prevention including nPEP and PrEP.
|
Tuesday, 7/25/2023 12:00 pm – 1:30 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community. |
Topic: Buprenorphine
This training will cover a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention will be directed towards effective measures that support the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
|
Tuesday, 7/25/2023 3:00 pm – 4:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.